Biotech · Private company
Valent Technologies, LLC
Track this companyFree. Adds Valent Technologies, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- TemozolomidePhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- VAL-413Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 25, 2021ClinicalTrials.gov NCT04337177 · fetched Nov 12, 2026